EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, INM: Inmed Pharmaceuticals Inc

28 Oct 25 15:59
LAST:

2.000

CHANGE:
 0.04		OPEN:
2.030		HIGH:
2.052		ASK:
0.000		VOLUME:
51.5K
CHG(%):
1.96		PREV:
2.040		LOW:
2.000		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
28 Oct 252.0402.0522.0002.00054.2K
27 Oct 252.0602.1032.0402.04032.9K
24 Oct 252.0402.1402.0402.07050.5K
23 Oct 252.0602.1002.0202.03043.4K
22 Oct 252.1002.1502.0202.06094.2K
21 Oct 252.1602.1702.1102.16032.6K
20 Oct 252.1002.1802.0902.15015.3K
17 Oct 252.0802.2202.0702.10077.7K
16 Oct 252.2202.2602.0702.08074.4K
15 Oct 252.1602.2102.1202.20068.0K

COMPANY PROFILE

Name:Inmed Pharmaceuticals Inc
About:InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States. The company operates through two segments, InMed Pharmaceuticals and BayMedica Commercial. The InMed Pharmaceuticals segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica Commercial segment develops proprietary manufacturing technologies to produce and sell rare cannabinoids for the health and wellness industry. Its prescription-based products include rare cannabinoids and novel cannabinoid analogs for the treatment of diseases with unmet medical needs. The company's lead product consists of INM-755, a cannabinol topical skin cream that has completed Phase 2 clinical trial for the treatment of epidermolysis bullosa. It also develops INM-089, a small molecule compound that acts as a selective dual CB1/CB2 agonist; and INM-900 for neurodegenerative diseases, as well as INM-901, a small molecule for treatment of Alzheimer's disease. In addition, the company offers IntegraSyn, an integrated biosynthesis-based manufacturing approach for pharmaceutical-grade cannabinoids; and cannabichromene, cannabicitran, cannabidivarin, and tetrahydrocannabivarin. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada.
Sector:Healthcare
Address:885 West Georgia Street, Vancouver, BC, Canada, V6C 3E8
Website:https://www.inmedpharma.com
CUSIP:457637502
CIK:0001728328
ISIN:CA4576375022
FIGI:BBG000BT4589

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:2.042.0%
MA10:2.094.5%
MA20:2.178.6%
MA50:2.209.8%
MA100:2.4421.8%
MA200:2.6934.6%
RSI14:23.07 
WPR14:-100.00 
MTM14:-0.35
ROC14:-0.15 
ATR:0.12 
Week High:2.178.5%
Week Low:2.000.0%
Month High:2.5025.0%
Month Low:2.0034.6%
Year High:8.27313.5%
Year Low:0.22830.2%
Volatility:39.90 

RECENT SPLITS

Date Ratio
14 Nov 20241-20
07 Sep 20221-25
06 Jul 20201-33